Clinical trial

Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA

NCT04247815

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ATI-450 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo oral tablet Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-03-16

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

ATI-450DRUG

Placebo oral tabletDRUG

MethotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Aclaris Therapeutics, Inc.lead sponsor

Mapped research locations

AtlantaGeorgia, United States1 TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04247815 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.